Last reviewed · How we verify

NCT05364606

Patient Specific Talus Spacer Post Approval Study

Recruiting now Last updated 7 November 2024
What this trial tests

trial testing Patient Specific Talus Spacer in Avascular Necrosis of the Talus in 50 participants. Currently enrolling.

Timeline
8 July 2022
Primary endpoint
30 August 2029
30 November 2029

Quick facts

Lead sponsorParagon 28
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date8 July 2022
Primary completion30 August 2029
Estimated completion30 November 2029
Sites6 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Paragon 28

Who can join

21 and older, any sex, with Avascular Necrosis of the Talus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Humanitarian Device Exemption Approved Patient Specific Talus Spacer Post Approval Study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Avascular Necrosis of the Talus

Currently open trials in the same condition.

Other Paragon 28 trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05364606.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing